The Aporphine Alkaloid Dicentrine and Its N-Oxide Derivatives Inhibit Akt Pathway in Head and Neck Cancer Cell Lines and Induce Anti-Inflammatory Response Independent of TP53 Status
ACS Omega · 12.11.2026
DOI: 10.1021/acsomega.6c10724 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Omega, online erschienen am 12.11.2026. Verfasst von Natália Meneses Araújo und 10 weiteren Autor:innen. Die Arbeit nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Conselho Nacional de Desenvolvimento Cient?fico e Tecnol?gico, Funda??o de Amparo ? Pesquisa do Estado de S?o Paulo, Coordena??o de Aperfei?oamento de Pessoal de N?vel Superior.
Abstract (Originalsprache)
Head and neck squamous cancers (HNSC) are a group of heterogeneous tumors that frequently have TP53 mutations associated with a worse prognosis and poor response to treatment. Current therapy combines chemotherapy and radiotherapy for both early and advanced diseases, underscoring the need for new drugs to improve conventional therapy. In recent years, natural product research has increasingly focused on the discovery and development of anticancer agents. Dicentrine (1), for example, is an aporphine alkaloid isolated from the leaves of Ocotea puberula. Dicentrine and its N-oxide derivatives (compounds 1a and 1b) have demonstrated cytotoxic activity against tumor cells, highlighting their potential as bioactive natural-product scaffolds. As a continuation of our studies, the present work investigated the antitumor potential of compounds 1, 1a, and 1b in head and neck squamous cell carcinoma (HNSCC) cell lines with distinct TP53 statuses, namely, FaDu (TP53 mutant) and SCC143 (TP53 wild-type) cells. In vitro studies through cell viability, colony formation assay, cell death, and in silico analysis through molecular docking and molecular dynamics simulations demonstrated that compound 1b has lost its antitumor activity, while compounds 1 and 1a inhibited colony formation, decreased cell viability, and induced cell death independently of TP53 status. We also demonstrated that compounds 1 and 1a decreased HMGB1, IL18, and Akt expression. Our in silico analysis suggested that compounds 1 and 1a adopt a productive binding mode at the AKT1 kinase, whereas p53 is not a stable target. Such findings provide additional evidence for the use of compounds 1 and 1a as therapeutic drugs also for head and neck cancer.
Förderung
- Conselho Nacional de Desenvolvimento Cient?fico e Tecnol?gico
- Funda??o de Amparo ? Pesquisa do Estado de S?o Paulo
- Coordena??o de Aperfei?oamento de Pessoal de N?vel Superior
Zitieren
APA
Araújo, N. M., Tristão, D. D. C., Farias, A. B., Chanes, G. B., Machado, R. S., Dias, L. M. P., Gomes, K. D. S., Rubio, I. G. S. D., Cerchiaro, G., Lago, J. H. G., & Tamura, R. E. (2026). The Aporphine Alkaloid Dicentrine and Its N-Oxide Derivatives Inhibit Akt Pathway in Head and Neck Cancer Cell Lines and Induce Anti-Inflammatory Response Independent of TP53 Status. ACS Omega. https://doi.org/10.1021/acsomega.6c10724
Vancouver
Araújo NM, Tristão DDC, Farias AB, Chanes GB, Machado RS, Dias LMP, et al. The Aporphine Alkaloid Dicentrine and Its N-Oxide Derivatives Inhibit Akt Pathway in Head and Neck Cancer Cell Lines and Induce Anti-Inflammatory Response Independent of TP53 Status. ACS Omega. 2026. doi:10.1021/acsomega.6c10724
BibTeX
@article{Araujo2026,
author = {Araújo, Natália Meneses and Tristão, Daniela da Costa and Farias, Augusto Batista and Chanes, Giovanna Barbosa and Machado, Ranyelison Silva and Dias, Laura Maria Pinto and Gomes, Kaio de Souza and Rubio, Ileana Gabriela Sanchez de and Cerchiaro, Giselle and Lago, João Henrique Ghilardi and Tamura, Rodrigo Esaki},
title = {The Aporphine Alkaloid Dicentrine and Its N-Oxide Derivatives Inhibit Akt Pathway in Head and Neck Cancer Cell Lines and Induce Anti-Inflammatory Response Independent of TP53 Status},
journal = {ACS Omega},
year = {2026},
doi = {10.1021/acsomega.6c10724}
}
EUVIMED